Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

p53 anticorps

Cet anticorps anti-p53 est un anticorps Souris Monoclonal détectant p53 dans WB, IHC et ELISA. Adapté pour Humain. Ce Primary Antibody a été cité dans 2+ publications.
N° du produit ABIN969336

Aperçu rapide pour p53 anticorps (ABIN969336)

Antigène

Voir toutes p53 (TP53) Anticorps
p53 (TP53) (Tumor Protein P53 (TP53))

Reactivité

  • 883
  • 271
  • 222
  • 136
  • 72
  • 71
  • 62
  • 38
  • 11
  • 10
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 644
  • 258
  • 5
  • 2
  • 2
Souris

Clonalité

  • 563
  • 347
  • 1
Monoclonal

Conjugué

  • 465
  • 46
  • 32
  • 20
  • 18
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 12
  • 12
  • 12
  • 12
  • 12
  • 11
  • 11
  • 10
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Cet anticorp p53 est non-conjugé

Application

  • 680
  • 263
  • 246
  • 235
  • 194
  • 135
  • 129
  • 122
  • 112
  • 66
  • 65
  • 60
  • 35
  • 19
  • 17
  • 12
  • 10
  • 10
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Clone

4A8
  • Fonction

    p53 Antibody

    Purification

    Ascitic fluid

    Immunogène

    Purified recombinant fragment of human p53 expressed in E. Coli.

    Isotype

    IgG1
  • Indications d'application

    ELISA: 1/10000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Ascitic fluid containing 0.03 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Sengpiel, König, Rades, Noack, Duchrow, Schild, Ludwig, Homann: "p53 Mutations in carcinoma of the esophagus and gastroesophageal junction." dans: Cancer investigation, Vol. 27, Issue 1, pp. 96-104, (2009) (PubMed).

    Ecke, Schlechte, Hübsch, Lenk, Schiemenz, Rudolph, Miller: "TP53 mutation in prostate needle biopsies--comparison with patients follow-up." dans: Anticancer research, Vol. 27, Issue 6B, pp. 4143-8, (2008) (PubMed).

  • Antigène

    p53 (TP53) (Tumor Protein P53 (TP53))

    Autre désignation

    p53

    Sujet

    P53 responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor activity. Alterations of this gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative promoters and multiple alternative splicing have been found. These variants encode distinct isoforms, which can regulate p53 transcriptional activity.

    Poids moléculaire

    43.7 kDa

    ID gène

    7157

    UniProt

    P04637

    Pathways

    Signalisation p53, Signalisation MAPK, Signalisation PI3K-Akt, Apoptose, AMPK Signaling, Chromatin Binding, ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Autophagy, L'effet Warburg
Vous êtes ici:
Chat with us!